US Patent Issued to Amicus Therapeutics on April 14 for "Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,595, issued on April 14, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones" was invented by Jeff Castelli (New Hope, Pa.) and David J. Lockhart (Emerald Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides dosing regimens for administering pharmacological chaperones to a subject in need thereof. The dosing regimens can be used to treat disorders caused by improper protein misfolding, such as lysosomal storage disorders."

The patent was filed on May 18, 2023, under Application No. 18/199,125.

*For further ...